Global Interventional Cardiology Market
Interventional cardiology is the catheter-based treatment of cardiovascular diseases. Certified cardiologists who perform these procedures are known as intervention cardiologists. Interventional procedures are mostly performed in specialized catheterization laboratories using cardiac monitoring devices and other cardiac medical devices. The procedures are considered minimally invasive since they do not require large incisions to be made in the body. It involves the insertion of a catheter or hollow tube into the body.
The interventional cardiology market is poised to grow at a steady rate over the forecast period given that the use of interventional cardiology devices has increased significantly. Public as well as private sector hospitals have started using interventional cardiology products. The global interventional cardiology market is likely to grow at a CAGR of 6.9% (2017-2022) resulting in a global revenue of USD 21.88 billion by 2022.
The stents as well as catheters segment are expected to grow at a significant rate. Among the various applications, the angioplasty segment has held the maximum share of the market and is expected to grow at a considerable rate over the forecast period. Valvuloplasty is the other application area that is likely to gain momentum, especially in pediatric interventional cardiology.
Key growth factors
The development of advanced minimally invasive procedures and increase in adoption of the same in interventional cardiology is likely to drive the global market in the future. Moreover, the development of hybrid procedures is another trend that is likely to gain acceptance across the industry in the coming years.
Increasing number of people with heart diseases around the world, rise in population, and growth of pediatric heart diseases are some of the other factors that are expected to push the progress of the overall interventional cardiology market in a growth trajectory.
Threats and key players
Despite the optimistic growth forecast of the interventional cardiology market, some restraining factors must be taken into consideration while analyzing the overall market scenario. Post-procedural complexities such as blood clotting or thrombosis, uneven drug release, and varying rates of degradation are some of the factors that may hinder the growth of the market.
Moreover, the market scenario of interventional cardiology is very dynamic. The intensity of competition among companies is reasonably high. Price cuts offered by small and medium players on their devices compel established players to reduce their profit margins, thereby leading to an inhibition of the research and development efforts owing to lack of funds. This may become a strong restraining factor in the extended long term.
Some of the major players in the Interventional Cardiology market are Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Livanova, PLC, Abbott Laboratories, S.A., C. R. Bard, Inc., Johnson & Johnson Pvt. Ltd., B. Braun Melsungen AG, Teleflex Incorporated, and Microport Medical Apparatus(Shanghai) Co. Ltd.
What's covered in the report?
1. Overview of the Global Interventional Cardiology Market
2. Historical, current and forecasted market size data for global Stents, Catheters, and Others.
3. Historical, current and forecasted market size data for global Angioplasty, and Valvuloplasty application areas
4. Historical, current and forecasted regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) market size data for Stents, Catheters, Angioplasty, Valvuloplasty, and Others
5. History and future of Interventional Cardiology
6. Value Chain Analysis of Interventional Cardiology Market
7. Analysis of Stakeholders and Ecosystem in Interventional Cardiology for different segments
8. Qualitative analysis of the major drivers and challenges affecting the Global Interventional Cardiology Market and Stents, Catheters, Angioplasty, Valvuloplasty and Others
9. Analysis of the competitive landscape and profiles of major public and private players operating in the market
10. Key recent developments relating to the Stents, Catheters, Angioplasty, Valvuloplasty and Others
11. Market relating to the Stents, Catheters, Angioplasty, Valvuloplasty and Others
Why buy?
1. Get a broad understanding of the Global Interventional Cardiology Market and Stents, Catheters, Angioplasty, Valvuloplasty and Others sectors
2. Get Region-specific drivers and challenges affecting the Global Interventional Cardiology Market and Stents, Catheters, Angioplasty, Valvuloplasty and Others sectors
3. Devise market-entry strategies by understanding the factors driving the growth of the market
4. Recognize major competitors' business and market dynamics, and respond accordingly
5. Get stakeholder analysis, relevant company profiles
Customizations Available
With the given market data, Research on Global Markets offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com.
Chapter 1: Executive Summary
1.1. Market Scope and Segmentation
1.2. Key Questions Answered in This Study
1.3. Executive Summary
Chapter 2: Introduction - Interventional Cardiology Market
2.1. Introduction
2.2. Difference between Non-Invasive Cardiology and Interventional Cardiology
2.3. Value Chain Analysis
Chapter 3: Timeline - Interventional Cardiology Market
3.1. A brief history of Interventional Cardiology
3.2. Evolution of Interventional Cardiology
3.3. The Future of Interventional Cardiology
Chapter 4: Interventional Cardiology Market Overview
4.1. Global Interventional Cardiology Market Overview
4.2. Geographical Market Share Study
4.3. Interventional Cardiology Market Drivers
4.4. Interventional Cardiology Market Trends
Chapter 5: Regional Overview
5.1. North America
-Overview
-Revenue
-Drivers
-Trends
5.1. Asia Pacific
-Overview
-Revenue
-Drivers
-Trends
5.1. Europe
-Overview
-Revenue
-Drivers
-Trends
5.1. Latin America
-Overview
-Revenue
-Drivers
-Trends
5.1. Middle East and Africa
-Overview
-Revenue
-Drivers
-Trends
Chapter 6: Segmentation Overview-By Type
6.1. Stents
-Overview
-Analysis
-Total Revenue
-Geographic Revenue
-Top 5 companies in this segment
-Trends
6.2. Catheters
-Overview
-Analysis
-Total Revenue
-Geographic Revenue
-Top 5 companies in this segment
-Trends
6.3. Others
-Overview
-Analysis
-Total Revenue
-Geographic Revenue
-Top 5 companies in this segment
-Trends
Chapter 7: Segmentation Overview-By Application
7.1. Angioplasty
-Overview
-Analysis
-Total Revenue
-Geographic Revenue
-Top 5 companies in this segment
-Trends
7.2. Valvuloplasty
-Overview
-Analysis
-Total Revenue
-Geographic Revenue
-Top 5 companies in this segment
-Trends
Chapter 8: Company Profiles
8.1. Medtronic PLC
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.2. Boston Scientific Corporation
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.3. Edwards Lifesciences Corporation
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.4. Terumo Corporation
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.5. Livanova, PLC
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.6. Abbott Laboratories, S.A.
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.7. C. R. Bard, Inc.
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.8. Johnson & Johnson Pvt. Ltd.
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.9. B. Braun Melsungen AG
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.10. Teleflex Incorporated
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.11. Microport Medical Apparatus (Shanghai) Co. Ltd.
-Management Team
-Company Snapshot
-Key Numbers
-Strategy and Initiatives
-Geographical Presence
8.12. Global Competitive Landscape
Chapter 9: Conclusion
Chapter 10: Appendix
11.1 List of Tables
11.2 Research Methodology
11.3 About Netscribes
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
In Korea, Private Health Insurance means private insurance plans introduced to supplement the National Health Insurance Service, the nationwide public health insurance system.
When the insured with illness or injury receive medical treatments such as hospital stay, out-patient care or prescri...
Executive Summary
Azoth Analytics has released a research report titled Global Low Carbon Ammonia Market (2024 Edition) which provides a complete analysis of the Global Low Carbon Ammonia industry in terms of market segmentation By Type (Green Ammonia, and Blue Ammonia), By Technology...